Indu Bala and Pranav Kumar Prabhakar
Background: Thymosin alpha 1 is a peptide naturally occurring in the thymus that has long been recognized for modifying, enhancing, and restoring immune function.
Purpose: The present study focuses on the effects of Thymosin alpha 1 on Body weight, Paw weight, paw volume and arthritic score of Collagen induced arthritis (CIA) rats.
Methods: The wistar rats were randomly divided into 5 groups: nor-mal control, arthritic control, CIA+Ta-1 0.25mg/kg, CIA+Ta-1 0.5mg/kg and CIA+Ta-1 mg/kg. The collagen and lipopolysaccharide (LPS) were administered via the intraplantar route to the experimental rat subjects. Prior to the administration of collagen and LPS, the initial paw volume was measured, and the body weight was duly document-ed. The administration of the treatment occurred on the first, third, and fifth days. On the completion of the dosing period, specifically on the fifteenth day, the final body weight was duly recorded. The measurements of paw volume, paw weight, Body weight and arthritic score were duly recorded.
Results: Following with the administration of Thymosin alpha-1 the arthritic rats shown significantly reduce the severity of arthritis by decreasing the symptoms of arthritis.
Conclusions: Thymosin alpha-1 has shown a promising effect of the reduction in the pathophysiology of rheumatoid arthritis and hence it can be a better therapeutic candidate of future for the management of RA. The more detailed analysis of the mechanistic study may provide a better understanding
Bax, M., van Heemst, J., Huizinga, T. W., & Toes, R. E. (2011). Genetics of rheumatoid arthritis: what have we learned? Immunogenetics, 63, 459-466.
Brand DD, Latham KA, Rosloniec EF. (2007). Collagen induced arthritis. Nature Protocol 2:1269–75.
Conteas, C. N., Mutchnick, M. G., Palmer, K. C., Weller, F. E., Luk, G. D., Naylor, P. H., … & Horecker, B. L. (1990). Cellular levels of thymosin immunoreactive peptides are linked to proliferative events: evidence for a nuclear site of action. Proceedings of the National Academy of Sciences, 87(9), 3269-3273.
Dhawan, S. S., & Quyyumi, A. A. (2008). Rheumatoid arthritis and cardiovascular disease. Current atherosclerosis reports, 10(2), 128–133. https://doi.org/10.1007/s11883-008-0019-x
Egan CG, Lockhart JC, Ferrell WR. (2004). Pathophysiology of vascular dysfunction in a rat model of chronic joint inflammation. J Physiol 557:635–45.
Fiorentino PM, Talents RH, Miller JN, et al. (2008). Spinal interleukin-1b in a mouse model of arthritis and joint pain. Arthritis Rheum 58:3100–9.
Gomez-Marquez, J., Segade, F., Dosil, M., Pichel, J. G., Bustelo, X. R., & Freire, M. (1989). The expression of prothymosin α gene in T lymphocytes and leukemic lymphoid cells is tied to lymphocyte proliferation. Journal of Biological Chemistry, 264(15), 8451-8454.
Granado M, Preigo T, Lopez- Calderon A, et al. (2005). Anti-inflammatory effect of the ghrelin agonist growth hormone-releasingpeptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab288:486–92.
Gupta, A., & Singh, S. (2014). Evaluation of anti-inflammatory effect of Withania somnifera root on collagen-induced arthritis in rats. Pharmaceutical biology, 52(3), 308-320.
Jevremovic, M., Kartaljevic, G., Jelusic, V., Vodnik, T., Pesic, M., & Filipovic, S. (1997). Determination of thymosin alpha1 with enzyme-immunoassay in colorectal cancer patients. Archive of Oncology, 5(4), 193-194.
Kremer JM. (2001). Rational use of new and existing disease modifying agents in rheumatoid arthritis. Ann Intern Med 134:695–706.
Kuijper, T. M., Lamers-Karnebeek, F. B., Jacobs, J. W., Hazes, J. M., &Luime, J. J. (2015). Flare rate in patients with rheumatoid arthritis in low disease activity or remission when tapering or stopping synthetic or biologic DMARD: a systematic review. The Journal of rheumatology, 42(11), 2012-2022.
Kumar N, Singh S, Patro N, Patro I. (2009). Evaluation of protective efficacy of Spirulina platensis against collagen induced arthritis in rats. Inflammo pharmacology 17:181–90.
Moreland LW, Russel AS, Paulus HE. (2001). Management of rheumatoid arthritis: The historical context. J Rheumatol 28:1431–52.
Pica, F., Chimenti, M. S., Gaziano, R., Buè, C., Casalinuovo, I. A., Triggianese, P., … & Garaci, E. (2016). Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases. Clinical & Experimental Immunology, 186(1), 39-45.
Rasool M, Sabina EP, Lavanya B. (2006). Anti-inflammatory effect of Spirulina fusiformis on adjuvant-induced arthritis in mice. Biol Pharm Bull 29:2483–7.
Sewerin, P., Vordenbaeumen, S., Hoyer, A., Brinks, R., Buchbender, C., Miese, F., … & Ostendorf, B. (2017). Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort. BMC musculoskeletal disorders, 18, 1-9.
Shejawal, N., Menon, S., & Shailajan, S. (2014). A simple, sensitive and accurate method for rat paw volume meas urement and its expediency in preclinical animal studies. Human & experimental toxicology, 33(2), 123-129.
Smolen, J. S., Landewé, R. B., Bijlsma, J. W., Burmester, G. R., Dougados, M., Kerschbaumer, A., … & Van Der Heijde, D. (2020). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the rheumatic diseases, 79(6), 685-699.
Toh, M. L., &Miossec, P. (2007). The role of T cells in rheumatoid arthritis: new subsets and new targets. Current opinion in rheumatology, 19(3), 284-288.
Weyand, C. M., & Goronzy, J. J. (1997). Pathogenesis of rheumatoid arthritis. Medical Clinics, 81(1), 29-55.
Zhang, Q., Tang, D., & Zhao, H. (2010). Immunological therapies can relieve aromatase inhibitor-related joint symptoms in breast cancer survivors. American journal of clinical oncology, 33(6), 557-560.
| Periodicity | Biannually |
| Issue-1 | October |
| Issue-2 | April |
| ISSN Print | 2393-8536 |
| ISSN Online | 2393-8544 |
| RNI No. | CHAENG/2014/57978 |
Publisher's policy of the journal at Sherpa UK for the submitted, accepted, and published articles. Click OAPolicy
Plan-S ComplianceTo check compliance, one has to use the Journal Check Tool (JCT). This tool provided by cOAlition S (European funders) for the researchers (fundee) to check the compliance with the journal.
Recommend journal to your libraryYou can recommend the journal being a researcher or faculty member to your library. We will post a copy of the Journal to your library on your behalf at free of cost.
Click here: Recommend Journal
The authors are encouraged to submit the author’s copy (preprint) to appropriate preprint archives e.g. https://arxiv.org and/or on https://indiarxiv.org or institutional repositories (e.g., D Space) before paper acceptance by the editor of Journal. After publications of the paper author(s) should mention the citation information, title and abstract along with DOI number of the publication carefully on the required page of the depository(ies).
Contact:Phone: +91-172-2741000, +91-172-4691800
Email : editor.jmrh@chitkara.edu.in
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles in Journal of Multidisciplinary Research in Healthcare by Chitkara University Publications are Open Access articles that are published with licensed under a Creative Commons Attribution- CC-BY 4.0 International License. Based on a work at https://jmrh.chitkara.edu.in/. This license permits one to use, remix, tweak and reproduction in any medium, even commercially provided one give credit for the original creation.
View Legal Code of the above-mentioned license, https://creativecommons.org/licenses/by/4.0/legalcode
View Licence Deed here https://creativecommons.org/licenses/by/4.0/
Journal of Multidisciplinary Research in Healthcare by Chitkara University Publications is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at https://jmrh.chitkara.edu.in/
Chandigarh-Patiala National Highway, Punjab 140 401
Chandigarh Information Center SCO 160-161, Sector 9-C, Chandigarh 160 009
